Welcome to our dedicated page for Leidos Holdings news (Ticker: LDOS), a resource for investors and traders seeking the latest updates and insights on Leidos Holdings stock.
Leidos Holdings, Inc. (NYSE: LDOS) is a leading science and technology company that provides services and solutions in defense, intelligence, civil, and health markets. Headquartered in Reston, Virginia, Leidos leverages the expertise of its 47,000 employees to tackle some of the world's most pressing challenges. The company is divided into several segments, each catering to specific industries:
- National Security and Digital: Focuses on cyber, logistics, security operations, and digital transformation for defense and intelligence customers.
- Health & Civil: Delivers public health solutions, care coordination, and environmental sciences services.
- Commercial & International: Covers security enterprise solutions, commercial energy offerings, and international business.
- Defense Systems: Develops advanced space, aerial, surface, and subsurface defense systems.
Leidos reported revenues of approximately $15.4 billion for the fiscal year ending December 29, 2023. The company’s recent projects include:
- Development of C2IMERA: An advanced command and control tool for the U.S. Air Force.
- MHS GENESIS Deployment: A federal electronic health record system implemented across all Department of Defense garrison facilities.
- Mayhem Hypersonic System: Advancing air-breathing hypersonic technologies through a collaborative national team effort.
Financially, Leidos had a strong 2023 with revenues up by 7%, achieving a record net income margin of 7.1% in the first quarter of 2024. The company remains committed to innovation, operational efficiency, and addressing emerging threats in national security and health.
Rhea-AI Summary
Leidos (NYSE: LDOS) has been awarded a $700 million prime contract to provide prototype and technology development support to the National Security Agency (NSA). The company will develop next-generation technology solutions for the intelligence community, focusing on identifying emerging technologies, developing new tools and techniques, and supporting the NSA's intelligence and cyber missions. Leidos will provide subject matter expertise to develop and maintain technology, tools, and techniques in support of the analyst community. This new contract continues Leidos' long-standing support for the NSA and the intelligence community.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.07%
Tags
-
Rhea-AI Summary
Leidos (NYSE: LDOS) successfully completed the Lonestar tactical space support vehicle's on-orbit demonstration, providing space-based situational awareness for the tactical warfighter. The technology demonstrator launched on July 1, 2022, and exceeded expectations, gathering vital data and observations. Lonestar demonstrated new technology for GPS interference warning and utility for tactical users, endorsed by the Space Development Agency as a pathfinder for navigation capabilities for the Proliferated Warfighter Space Architecture.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.65%
Tags
-
Rhea-AI Summary
Leidos (LDOS) successfully deploys SkyLine-X™ Air Traffic Management system in collaboration with Airways New Zealand. The deployment introduces a virtual multi-channel architecture, enhanced safety surveillance tracker, and upgraded modeler for Trajectory Based Operations (TBO), promising safer, more efficient, and sustainable air navigation services.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.93%
Tags
Rhea-AI Summary
Leidos (LDOS) awarded a $32 million contract by MARCORSYSCOM through CMG for the development of four MRADR prototype systems. The Dynetics team will lead the development. Leidos' previous sensor development programs and successful R&D process contributed to this win. Work primarily in Huntsville, Alabama, with some labor in Arlington, Virginia. Delivery date scheduled for 2025.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.01%
Tags
-
News
Rhea-AI Summary
Leidos Partnership (LPDH) successfully delivered the MHS GENESIS electronic health record (EHR) to an additional 7,000 Department of Defense (DOD) clinicians and providers as part of a second Outside of the Contiguous United States (OCONUS) deployment (Waves OKINAWA/S. KOREA). This deployment marks the completion of 23 MHS GENESIS waves, with the system now operational at over 3,700 locations and reaching over 183,000 users and 7.4 million DOD beneficiaries. LPDH continues its global roll-out of the EHR system, aiming for 100% system deployment early next year. The company has been providing program management and technical expertise to the Program Executive Office Defense Healthcare Management Systems since 2015.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.56%
Tags
-
Rhea-AI Summary
Leidos (NYSE:LDOS) successfully deployed the Exploration Potable Water Dispenser (xPWD) for the International Space Station, providing potable-quality water for astronauts and featuring innovative technology designed to ensure long-term functionality and sustainability.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.49%
Tags
Rhea-AI Summary
Leidos announces a realignment of its operating groups and changes to its corporate leadership structure and personnel, effective Jan. 1, 2024. The company will be organized into five sectors: Health and Civil Sector, National Security Sector, Commercial and International Sector, Digital Modernization Sector, and Defense Systems Sector. Leidos also appoints Cindy Gruensfelder as President of the Defense Systems Sector, bringing extensive Aerospace and Defense platform engineering and program management experience. Gerry Fasano will become Chief Growth Officer, Carly Kimball will become Chief Performance Officer, and other members of the executive leadership team will continue in their current roles.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.98%
Tags
-
Rhea-AI Summary
Leidos Holdings, Inc. reports Q3 2023 financial results with revenues of $3.9 billion, up 9% YoY. The company had a net loss of $396 million or $2.91 per diluted share. Adjusted EBITDA was $451 million with a margin of 11.5%. Non-GAAP Diluted Earnings per Share was $2.03, up 28% YoY. Cash Flows from Operations were $795 million with free cash flow of $745 million. Net Bookings were $7.9 billion with a book-to-bill ratio of 2.0 for the quarter. Leidos is raising its guidance for all 2023 financial metrics.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.99%
Tags
-
Rhea-AI Summary
Leidos Holdings, Inc. (NYSE:LDOS) has declared a quarterly cash dividend of $0.38 per share, a $0.02 increase from the previous dividend. The dividend will be paid on December 29, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.44%
Tags
Rhea-AI Summary
Amwell and Leidos awarded contract to provide hybrid care technology platform for the Military Health System
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
15.47%
Tags
FAQ
What is the current stock price of Leidos Holdings (LDOS)?
The current stock price of Leidos Holdings (LDOS) is $158.84 as of November 18, 2024.
What is the market cap of Leidos Holdings (LDOS)?
The market cap of Leidos Holdings (LDOS) is approximately 21.3B.
What does Leidos Holdings, Inc. do?
Leidos Holdings, Inc. provides technology, engineering, and science solutions in defense, intelligence, civil, and health markets.
Where is Leidos Holdings, Inc. headquartered?
Leidos Holdings, Inc. is headquartered in Reston, Virginia.
How many employees does Leidos have?
Leidos employs approximately 47,000 people.
What are the main business segments of Leidos?
Leidos operates in four main segments: National Security and Digital, Health & Civil, Commercial & International, and Defense Systems.
What were Leidos' revenues for the fiscal year 2023?
Leidos reported revenues of approximately $15.4 billion for the fiscal year ending December 29, 2023.
What is C2IMERA?
C2IMERA is an advanced command and control tool developed by Leidos for the U.S. Air Force.
What is MHS GENESIS?
MHS GENESIS is a federal electronic health record system deployed by Leidos across all Department of Defense garrison facilities.
What recent project has Leidos completed for the Air Force Research Lab?
Leidos successfully completed key reviews for the Mayhem air-breathing hypersonic system for the Air Force Research Lab.
What are the recent financial highlights for Leidos?
For the first quarter of 2024, Leidos reported a record net income margin of 7.1% and revenues of $3.98 billion.
How does Leidos contribute to national security?
Leidos provides advanced technology solutions for defense and intelligence clients, including cybersecurity, logistics, and security operations.
Leidos Holdings, Inc.
NYSE:LDOS
LDOS Rankings
LDOS Stock Data
21.34B
135.21M
1.09%
79.44%
1.06%
Information Technology Services
Services-computer Integrated Systems Design
United States of America
RESTON